Green Thumb Industries (GTBIF) Non-Current Assets (2019 - 2026)
Green Thumb Industries (GTBIF) posted Non-Current Assets of $2.2 billion for Q1 2026, down 2.49% on a QoQ basis from $2.2 billion in Q4 2025, and up 1.58% year-over-year from $2.1 billion in Q1 2025.
Green Thumb Industries (GTBIF) Non-Current Assets (2019 - 2026) Analysis & Trends
Green Thumb Industries' Non-Current Assets history runs 8 years deep, the most recent figure standing at $2.2 billion for Q1 2026.
- Quarterly Non-Current Assets rose 1.58% year-over-year to $2.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.7 billion (up 1.86% YoY) and the FY2025 annual result came in at $2.2 billion, up 3.74% from the prior year.
- Non-Current Assets was $2.2 billion for Q1 2026 at Green Thumb Industries, down from $2.2 billion in the prior quarter.
- Across five years, Non-Current Assets topped out at $2.2 billion in Q4 2025 and bottomed at $1.7 million in Q1 2022.
- A 5-year average of $1.8 billion and a median of $2.1 billion in 2023 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2022 — Non-Current Assets plunged 51.12% — and 2023, when it surged 122421.86%.
- Green Thumb Industries' Non-Current Assets stood at $1.9 million in 2022, then soared by 112382.71% to $2.1 billion in 2023, then slipped by 0.66% to $2.1 billion in 2024, then rose by 3.74% to $2.2 billion in 2025, then dropped by 2.49% to $2.2 billion in 2026.
- Business Quant data shows GTBIF's Non-Current Assets at $2.2 billion in Q1 2026, $2.2 billion in Q4 2025, and $2.2 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 36.78 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 26.33 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 8.68 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 79.20 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 3.84 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.70 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 25.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.47 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 9.64 Bn |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn | 2.16 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.16 Bn |
| Dec 31, 2025 | 2.21 Bn |
| Sep 30, 2025 | 2.16 Bn |
| Jun 30, 2025 | 2.14 Bn |
| Mar 31, 2025 | 2.12 Bn |
| Dec 31, 2024 | 2.13 Bn |
| Sep 30, 2024 | 2.12 Bn |
| Jun 30, 2024 | 2.14 Bn |
| Mar 31, 2024 | 2.14 Bn |
| Dec 31, 2023 | 2.15 Bn |
| Sep 30, 2023 | 2.18 Bn |
| Jun 30, 2023 | 2.17 Bn |
| Mar 31, 2023 | 2.14 Bn |
| Dec 31, 2022 | 1.91 Mn |
| Sep 30, 2022 | 1.97 Mn |
| Jun 30, 2022 | 2.12 Bn |
| Mar 31, 2022 | 1.74 Mn |
| Dec 31, 2021 | 3.29 Mn |
| Sep 30, 2021 | 1.82 Mn |
| Jun 30, 2021 | 3.47 Mn |